Lipoxygenase metabolism of arachidonic acid in ischemic preconditioning and PKC-induced protection in heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 6 45-6, 1999, Pages

  Chen, Weina ^a   Glasgow, Wayne ^b   Murphy, Elizabeth ^c   Steenbergen, Charles ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

12(S) hydroperoxyeicosatetraenoic acid; 12 lipoxygenase; Eicosanoids

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYDECANOIC ACID; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONIC ACID; DIOCTANOIN; LIPOXYGENASE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ARTICLE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME METABOLISM; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SIGNAL TRANSDUCTION;

EID: 0033042426     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.6.h2094     Document Type: Article

References (35)

1. Auchampach, J. A., Grover, G. J., and G. J. Gross. Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc. Res. 26: 1054-62, 1992.
2. Bogoyevitch, M. A., P. J. Parker, and P. H. Sugden. Characterization of protein kinase C isotype expression in adult rat heart: protein kinase C-∈ is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ. Res. 72: 757-767, 1993.
3. Chen, W., W. Wetsel, C. Steenbergen, and E. Murphy. Effect of ischemic preconditioning and PKC activation on acidification during ischemia in rat heart. J. Mol. Cell. Cardiol. 28: 871-880, 1996.
4. Chien, K. R., A. Han, A. Sen, L. M. Buja, and J. T. Willerson. Accumulation of unesterified arachidonic acid in ischemic canine myocardium: relationship to a phosphatidylcholine deacylation-reacylation cycle and the depletion of membrane phospholipid. Circ. Res. 54: 313-322, 1984.
5. Chien, K. R., A. Sen, R. Reynolds, A. Chang, Y. Kim, M. D. Gunn, L. M. Buja, and J. T. Willerson. Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. J. Clin. Invest. 1770-1780, 1985.
6. + channels: possible mechanism of cardioprotection. Circ. Res. 81: 1072-1082, 1997.
7. Gross, G. J., and J. A. Auchampach. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-233, 1992.
8. Grover, G. J. An explanation for the reported observation that ATP dependent potassium channel openers mimic preconditioning. Cardiovasc. Res. 27: 1564, 1993.
9. Hager, J. M., S. L. Hale, and R. A. Kloner. Effect of preconditioning ischemia on reperfusion arrhythmias after coronary artery occlusion and reperfusion in rat heart. Circ. Res. 68: 61-68, 1991.
10. Karmazyn, M. Synthesis and relevance of cardiac eicosanoids with particular emphasis on ischemia and reperfusion. Can. J. Physiol. Pharmacol. 67: 912-921, 1989.
11. Kuzuya, T., S. Hoshida, M. Nishida, Y. Kim, T. Kamada, and M. Tada. Increased production of arachidonate metabolites in an occlusion-reperfusion model of canine myocardial infarction. Cardiovasc. Res. 21: 551-558, 1987.
12. Kuzuya, T., S. Hoshida, Y. J. Kim, H. Oe, M. Hori, T. Kamada, and M. Tada. Free radical generation coupled with arachidonate lipoxygenase reaction relates to reoxygenation induced myocardial cell injury. Cardiovasc. Res. 27: 1056-1060, 1993.
13. Lasley, R. D., G. M. Anderson, and R. M. Mentzer. Ischemic and hypoxic preconditioning enhances postischemic recovery of function in the rat heart. Cardiovasc. Res. 27: 565-570, 1993.
14. Liu, Y., and J. M. Downey, Ischemic preconditioning protects against infarction in rat heart. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H1107-H1112, 1992.
15. Liu, Y., T. Sato, B. O'Rourke, and E. Marban. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection. Circulation 97: 2463-2469, 1998.
16. McCluskey, E. R., S. Murphree, J. E. Saffitz, A. R. Morrison, and P. Needleman. Temporal changes in 12-HETE formation in two models of canine myocardial infarction. Prostaglandins 29: 387-403, 1985.
17. Mitchell, M. B., X. Meng, L. Ao, J. M. Brown, A. H. Harken, and A. Banerjee. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ. Res. 76: 73-81, 1995.
18. Murphy, E., W. Glasgow, T. Fralix, and C. Steenbergen. Role of lipoxygenase metabolites in ischemic preconditioning. Circ. Res. 76: 457-467, 1995.
19. Murry, C. E., V. J. Richard, K. A. Reimer, and R. B. Jennings. Ischemic preconditioning slows energy metabolism and delays ultrastructure damage during a sustained ischemic episode. Circ. Res. 66: 913-931, 1990.
20. Needleman, P., J. Turk, B. A. Jakschik, H. R. Morrison, and J. B. Lefkowith. Arachidonic acid metabolism. Annu. Rev. Biochem. 55: 69-102, 1986.
21. Nemenoff, R. A., S. Winitz, N. X. Qian, V. Van-Putten, G. L. Johnson, and L. E. Heasley. Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C. J. Biol. Chem. 268: 1960-1964, 1993.
22. Ping, P, J. Zhang, Y. Qiu, X.-L. Tang, S. Manchikalapudi, X. Cao, and R. Bolli. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ∈ and η in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ. Res. 81: 404-414, 1997.
23. Piomelli, D., and P. Greengard. Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signaling. Trends Pharmacol. Sci. 11: 367-373, 1990.
24. Qian, Y. Z., J. E. Levasseur, K. I. Toshida, and R. C. Kukreja. KATP channels in rat heart: blockade of ischemic and acetylcholine-mediated preconditioning by glibenclamide. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H23-H28, 1996.
25. Qiu, Z. H., and C. C. Leslie. Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2. J. Biol. Chem. 269: 19480-19487, 1994.
26. Rybin, V. O., and S. F. Steinberg. Protein kinase C isoform expression and regulation in the developing rat heart. Circ. Res. 74: 299-309, 1994.
27. + channels by protein kinase C. Circ. Res. 83: 110-114, 1998.
28. Schultz, J. E., Y. Z. Qian, G. J. Gross, and R. C Kukreja. The ischemia-selective KATP channel antagonist, 5-hydroxydecanoate, blocks ischemic preconditioning in the rat heart. J. Mol. Cell. Cardiol. 29: 1055-60, 1997.
29. Speechly-Dick, M. E., M. M. Mocanu, and D. M. Yellon. Protein kinase C: its role in ischemic preconditioning in the rat heart. Circ. Res. 75: 586-590, 1994.
30. Steenbergen, C., and R. B. Jennings. Relationship between lysophospholipid accumulation and plasma membrane injury during total in vitro ischemia in dog heart. J. Mol. Cell. Cardiol. 16: 605-621, 1984.
31. Steenbergen, C., M. E. Perlman, R. E. London, and E. Murphy. Mechanism of preconditioning: ionic alterations. Circ. Res. 72: 112-125, 1993.
32. Wu, S., C. Chen, E. Murphy, S. Gabel, K. B. Tomer, J. Foley, C. Steenbergen, J. R. Falck, C. R. Moomaw, and D. C. Zeldin. Molecular cloning, expression, and functional significance of a cytochrome P450 highly expressed in rat heart myocytes. J. Biol. Chem. 272: 12551-12559, 1997.
33. Yamamoto, S. Mammalian lipoxygenases: molecular structure and functions. Biochim. Biophys. Acta 1128: 117-131, 1992.
34. Yellon, D. M., A. M. Alkhulaifi, E. E. Browne, and W. B. Pugsley. Ischemic preconditioning limits infarct size in rat heart. Cardiovasc. Res. 26: 983-987, 1991.
35. Ytrehus, K., Y. Liu, and J. M. Downey. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1145-H1152, 1994.